Noopept – Research Chemical Description (FDA-Compliant)

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester; CAS No. 157115-85-0) is a synthetic peptide-derived research chemical that has been investigated for its potential influence on neurobiology and cognitive processes. Classified as a nootropic analogue, Noopept has drawn attention in laboratory settings for studies related to learning, memory pathways, neuroplasticity, and neuroprotection.

This compound is a high-purity research peptide supplied for in-vitro and laboratory research only. Noopept is not approved by the FDA for human consumption, diagnosis, treatment, or prevention of any disease.

Key Research Applications

• Neurochemical studies: Analysis of cholinergic, glutamatergic, and oxidative stress pathways.
• Peptide analog research: Comparative evaluation with compounds such as piracetam.
• Cognitive science research: Laboratory-based evaluation of memory, focus, and synaptic plasticity mechanisms.

Peer-Reviewed References (PubMed)

• Neznamov & Teleshova (2009) — Comparative studies of Noopept and piracetam in mild cognitive disorders PMID: 19234797
• Ostrovskaya et al. (2008) — Neuroprotective effect of novel cognitive enhancer Noopept PMC4422191
• Sokolov et al. (2021) — Noopept modulates persistent pain and spinal microglia in inflammation PMC7895721
• Zainullina et al. (2020) — Cognitive enhancer Noopept activates transcription factor HIF-1 PMID: 33119829

Important Notice

• For laboratory and scientific research only.
• Not for human or veterinary consumption.
• Handle in accordance with standard laboratory safety protocols.